CARGO Therapeutics, Inc. (CRGX)
(Real Time Quote from BATS)
$21.78 USD
+0.79 (3.76%)
Updated May 16, 2024 12:46 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for CARGO Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -98.15 | -40.95 | -5.85 | NA | NA |
Depreciation/Amortization & Depletion | 3.69 | 1.44 | 0.15 | NA | NA |
Net Change from Assets/Liabilities | 2.21 | 2.97 | 0.25 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 11.08 | 7.47 | 0.51 | NA | NA |
Net Cash From Operating Activities | -81.16 | -29.07 | -4.94 | NA | NA |
Property & Equipment | -8.28 | -2.72 | -0.44 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | -0.72 | -0.56 | 0.00 | NA | NA |
Net Cash from Investing Activities | -8.99 | -3.28 | -0.44 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 496.56 | 5.73 | 5.41 | NA | NA |
Issuance (Repayment) of Debt | 3.50 | 28.45 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -5.47 | 0.00 | 0.00 | NA | NA |
Net Cash from Financing Activities | 494.58 | 34.19 | 5.41 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | 404.43 | 1.83 | 0.03 | NA | NA |
Cash at Beginning of Period | 1.87 | 0.04 | 0.01 | NA | NA |
Cash at End of Period | 406.30 | 1.87 | 0.04 | NA | NA |
Diluted Net EPS | -16.53 | -104.40 | NA | NA | NA |
Fiscal Year End for CARGO Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -98.15 | -66.07 | NA | NA |
Depreciation/Amortization & Depletion | NA | 3.69 | 2.59 | NA | NA |
Net Change from Assets/Liabilities | NA | 2.21 | 2.56 | NA | NA |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | NA | NA |
Other Operating Activities | NA | 11.08 | 8.74 | NA | NA |
Net Cash From Operating Activities | NA | -81.16 | -52.18 | NA | NA |
Property & Equipment | NA | -8.28 | -5.66 | NA | NA |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | NA | NA |
Investments | NA | 0.00 | 0.00 | NA | NA |
Other Investing Activities | NA | -0.72 | -0.36 | NA | NA |
Net Cash from Investing Activities | NA | -8.99 | -6.02 | NA | NA |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 496.56 | 113.92 | NA | NA |
Issuance (Repayment) of Debt | NA | 3.50 | 3.50 | NA | NA |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | NA | NA |
Other Financing Activities | NA | -5.47 | -0.74 | NA | NA |
Net Cash from Financing Activities | NA | 494.58 | 116.67 | NA | NA |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | NA | 404.43 | 58.47 | NA | NA |
Cash at Beginning of Period | NA | 1.87 | 1.87 | NA | NA |
Cash at End of Period | NA | 406.30 | 60.34 | NA | NA |
Diluted Net EPS | NA | -1.49 | -47.37 | NA | NA |